Zobrazeno 1 - 3
of 3
pro vyhledávání: '"O. A. Ostapyuk"'
Autor:
A. Kh. Amandusova, A. E. Kovalenko, A. V. Morozov, K. R. Savelyeva, T. L. Batalova, O. A. Ostapyuk, L. V. Persanova, T. Yu. Andreevicheva, A. G. Beniashvili, V. N. Shestakov, S. V. Polyakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 2, Pp 95-102 (2023)
Introduction. Etoricoxib is a selective cyclooxygenase (COX-2) inhibitor used for the treatment of acute pain and has anti-inflammatory and analgesic efficacy. Etoricoxib causes fewer complications compared to other non-steroidal anti-inflammatory dr
Externí odkaz:
https://doaj.org/article/2ad4e1e393d04558be52a584df229d31
Autor:
K. R. Saveleva, T. Y. Andreevicheva, L. V. Persanova, O. A. Ostapyuk, S. V. Polyakov, V. N. Shestakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 4, Pp 50-54 (2019)
A new bifunctional ointment with chondroitin sulfate and celecoxib on a hydrophilic base was developed. The optimum conditions of the technology and technological properties of the ointment were determined. The techniques for quantitativecontrol of a
Externí odkaz:
https://doaj.org/article/3c633aeed1a04251ab6b5661978cb184
Autor:
T. L. Batalova, O. A. Ostapyuk, K. R. Saveleva, T. Y. Andreevicheva, L. V. Persanova, S. V. Polyakov, V. N. Shestakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 1, Pp 90-95 (2019)
A sensitive and developed the validation method for quantification by using the chromatograph for Etoricoxib. The method was validated in terms of specificity, linearity, accuracy, precision and analytical range. The results of validation method and
Externí odkaz:
https://doaj.org/article/3acbcd43d1d04576b2c3542fb9b65264